MedPath

High-frequency Ultrasound for Intraoperative Lymph Node Assessment in Gynecological Cancer: From Surgery to Radiomics

Not yet recruiting
Conditions
Gynecologic Cancer
Registration Number
NCT06906705
Lead Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Brief Summary

Lymph node assessment is crucial in gynecological cancers (ovarian, endometrial, cervical, and vulvar), as nodal involvement significantly impacts prognosis and treatment. Despite high morbidity, systematic lymphadenectomy has been widely used for staging and treatment planning. However, in most cases, lymph nodes are free from metastasis, making the procedure unnecessary and exposing patients to severe complications such as lymphedema and infections.

Sentinel lymph node (SLN) evaluation has emerged as a less invasive alternative, reducing unnecessary lymphadenectomies. However, SLN techniques face challenges, including detection failures, inaccurate frozen section analysis, and imaging limitations like false negatives in FDG PET/CT scans. The need for improved intraoperative imaging techniques is emphasized to enhance lymph node assessment, minimize surgical risks, and better tailor treatment approaches.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
Female
Target Recruitment
160
Inclusion Criteria
  • Women undergoing surgery for gynecological malignancies (ovarian, endometrial, cervical, and vulvar cancer)
  • Need for nodal excision (staging or cytoreductive reasons)
  • 18-99 years old
  • Absence of contemporary lymphatic diseases
  • Absence of previous oncological disease in the last 5 years
  • Willingness to participate in the study and to provide informed consent
Exclusion Criteria
  • Previous radiotherapy treatments
  • Previous chemotherapy treatments

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Evaluation of HFUS Accuracy in Detecting Lymph Node Metastases in Gynecological CancerDays 20

The aim of this prospective trial is to report the sensivity, specificity, NPV, PPV and accuracy of HFUS in the metastasis detection (macro, micro and ITCs) from fresh, unstained ex vivo/in vivo lymph node samples.

Secondary Outcome Measures
NameTimeMethod
Minimum Size Detection Limit of HFUS Imaging2 minutes

To assess the lowest size detectable with the adopted imaging technique

Development of a Radiomic Algorithm for Lymph Node Assessment6 months

To develop a radiomic algorithm for the assesment of the lymphn node status

Trial Locations

Locations (1)

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

🇮🇹

Roma, Italy

© Copyright 2025. All Rights Reserved by MedPath